Cited by

• De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy.

  Liu J, Huang S, Bi Z, Zhang X, He Z, Lan X, Tan Y, Lin X, Zhou W, Huang X. Liu J, et al. Front Oncol. 2023 Nov 1;13:1280900. doi: 10.3389/fonc.2023.1280900. eCollection 2023. Front Oncol. 2023. PMID: 38023183 Free PMC article.
• The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis.

  Wang S, Tang W, Luo H, Jin F, Wang Y. Wang S, et al. Clin Transl Radiat Oncol. 2022 Nov 8;38:81-89. doi: 10.1016/j.ctro.2022.11.001. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36407489 Free PMC article. Review.
• Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes.

  Yang L, Dong S, Gai S, Yang D, Ding H, Feng L, Yang G, Rehman Z, Yang P. Yang L, et al. Nanomicro Lett. 2023 Nov 21;16(1):28. doi: 10.1007/s40820-023-01224-0. Nanomicro Lett. 2023. PMID: 37989794 Free PMC article. Review.
• Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis.

  Tenti MV, Ingrosso G, Bini V, Mariucci C, Saldi S, Alì E, Zucchetti C, Bellavita R, Aristei C. Tenti MV, et al. Rep Pract Oncol Radiother. 2022 Mar 22;27(1):142-151. doi: 10.5603/RPOR.a2022.0012. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 35402018 Free PMC article.
• Gut Microbiota-Derived l-Histidine/Imidazole Propionate Axis Fights against the Radiation-Induced Cardiopulmonary Injury.

  Chen Z, Wang B, Dong J, Li Y, Zhang S, Zeng X, Xiao H, Fan S, Cui M. Chen Z, et al. Int J Mol Sci. 2021 Oct 23;22(21):11436. doi: 10.3390/ijms222111436. Int J Mol Sci. 2021. PMID: 34768867 Free PMC article.